Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

XingImaging Announces China Neuro-PET Scanning for Alzheimer's Trial
BeiGene Reports Positive PD-1 Data; Plans China NDA Filing This Year
WuXi Biologics Plans Another New CDMO Plant -- A $240 Million Facility in Shijiazhuang
Sinobioway to Invest $471 Million Build a CMO Site in Hefei
Biocytogen Closes $65 Million Round for Animal Model CRO Services
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Other Events



November 7–9, 2018

ChinaBio members can get a 20% discount with the promotion code"chinabio18"